RP-A501 (AAV9.LAMP2B)

Name: RP-A501 (AAV9.LAMP2B) in Danon disease: Product information
Published: 2026-10-08T12:19:25-04:00

Danon disease

Section

Product information

265 evidence topics · 105 sources

Generic, brand name and therapeutic class of product11 evidence topics · 12 sources
Dosage forms and strengths15 evidence topics · 15 sources
American hospital formulary service (AHFS), or other drug classification6 evidence topics · 10 sources
Indication10 evidence topics · 9 sources
Pharmacology44 evidence topics · 31 sources
Contraindications/Warnings/Precautions/Adverse effects67 evidence topics · 50 sources
Special populations31 evidence topics · 20 sources
Drug/Drug, drug/disease interactions10 evidence topics · 12 sources
Dosing and administration19 evidence topics · 19 sources
Access and distribution12 evidence topics · 11 sources
Co-prescribed/Concomitant therapies10 evidence topics · 15 sources
Effect of RP-A501 on quality measures12 evidence topics · 9 sources
Product comparison18 evidence topics · 21 sources

Not applicable.